DexCom (NASDAQ:DXCM) PT Raised to $150.00 at Piper Sandler :

DexCom (NASDAQ:DXCM – Free Report) had its target price increased by Piper Sandler from $135.00 to $150.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical device company’s stock. Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus […]

Related Keywords

United States , Stifel Nicolaus , Michael Jon Brown , Piper Sandler , Stevenr Altman , Securities Exchange Commission , Citigroup , Financial Gravity Asset Management Inc , Dexcom Inc , Valley National Advisers Inc , Harbour Investments Inc , Dexcom Company Profile , Kb Financial Partners , Avalon Trust Co , Free Report , Moderate Buy , Com Trading Down , Get Free Report , Jon Brown , Exchange Commission , Director Steven , Gravity Asset Management , Valley National Advisers , National Advisers , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,